Methyl 3-(bromoacetyl)phenoxyacetate | 63787-24-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Methyl 3-(bromoacetyl)phenoxyacetate
• 英文别名: Methyl 2-[3-(2-bromoacetyl)phenoxy]acetate
• CAS: 63787-24-6
• 化学式: C₁₁H₁₁BrO₄
• 分子量: 287.11
• InChiKey: MAMZOZLOEZLGKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  Methyl 3-(bromoacetyl)phenoxyacetate 在 sodium tetrahydroborate 、 N,N-二异丙基乙胺 作用下， 以 甲醇 、 二氯甲烷 、 水 为溶剂， 生成 [3-(1-Hydroxy-2-pyrrolidin-1-yl-ethyl)-phenoxy]-acetic acid methyl ester
  参考文献：
  名称：

  Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: Preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methods

  摘要：

  New analogues of the previously described 3-aryl pyridone KOR agonists have been synthesised by parallel synthetic methods, both in solution- and with solid-phase chemistry, making use of the well known and versatile Mitsunobu, Suzuki and Buchwald reactions. Opioid receptor binding data for the compounds produced is reported. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00033-7
• 作为产物：
  描述：

  methyl 2-(3-acetylphenoxy)acetate 在 乙酸甲酯 、 copper(ll) bromide 作用下， 以 氯仿 为溶剂， 生成 Methyl 3-(bromoacetyl)phenoxyacetate
  参考文献：
  名称：

  DD127474

  摘要：

  公开号：

文献信息

• Heterocyclic compouds
  申请人：Zeneca Limited

  公开号：US05753659A1

  公开（公告）日：1998-05-19

  A compound of the general formula (M.sup.1).sub.n --Q--(M.sup.2).sub.1-n --L--A I wherein: n is 0 or 1; M.sup.1 is an amino group; Q is an aromatic heterocyclic group containing a basic nitrogen atom; M.sup.2 is an imino group; L is a template group; and A is an acidic group, or an ester or amide derivative thereof, or a sulphonamide group; and pharmaceutically acceptable salts and pro-drugs thereof, for use in the treatment of a disease in which platelet aggregation mediated by the binding of adhesion molecules to GPIIb-IIIa is involved. Novel compounds are also disclosed.

  通式（M.sup.1).sub.n --Q--(M.sup.2).sub.1-n --L--A I的化合物，其中：n为0或1；M.sup.1为氨基；Q为含有碱性氮原子的芳香杂环基团；M.sup.2为亚胺基；L为模板基团；A为酸性基团，或其酯或酰胺衍生物，或磺酰胺基团；以及其药学上可接受的盐和前药，用于治疗通过粘附分子结合到GPIIb-IIIa介导的血小板聚集参与的疾病。还披露了新的化合物。
• .alpha.-Amino ketone derivatives
  申请人：Imperial Chemical Industries Limited

  公开号：US04105790A1

  公开（公告）日：1978-08-08

  The invention concerns .alpha.-aminoacyl derivatives of phenyl-, phenoxy-, thiophenoxy- and phenylsulphinylalkanoic acids together with their amides, esters and pharmaceutically acceptable salts; processes for their preparation; and pharmaceutical compositions for therapeutic use in inhibiting the formation of thrombi and also in reducing the persistence of thrombi formed in the blood of warm blooded animals. Representative compounds of the invention are methyl 4-(aminoacetyl)phenoxyacetate, 4-(aminoacetyl)phenoxyacetic acid and methyl 4-(aminoacetyl)-thiophenoxyacetate, preferably as their hydrochlorides.

  该发明涉及苯基、苯氧基、硫代苯氧基和苯基磺基烷酸的α-氨基酰衍生物，以及它们的酰胺、酯和药用盐；它们的制备方法；以及用于在温血动物的血液中抑制血栓形成并减少已形成血栓持续存在的治疗用药物组合物。该发明的代表性化合物包括甲基4-(氨基乙酰)苯氧乙酸酯、4-(氨基乙酰)苯氧乙酸和甲基4-(氨基乙酰)-硫代苯氧乙酸酯，最好以它们的盐酸盐形式。
• Structure-Based design, synthesis and sAR of a novel series of thiopheneamidine urokinase plasminogen activator inhibitors
  作者：Nalin L. Subasinghe、Carl Illig、James Hoffman、M.Jonathan Rudolph、Kenneth J. Wilson、Richard Soll、Troy Randle、David Green、Frank Lewandowski、Marie Zhang、Roger Bone、John Spurlino、Renee DesJarlais、Ingrid Deckman、Christopher J. Molloy、Carl Manthey、Zhau Zhou、Celia Sharp、Diane Maguire、Carl Crysler、Bruce Grasberger

  DOI：10.1016/s0960-894x(01)00247-5

  日期：2001.6

  The serine protease urokinase plasminogen activator (uPA) is thought to play a central role in tumor metastasis and angiogenesis. Molecular modeling studies suggest that 5-thiomethylthiopheneamidine inhibits uPA by binding at the S1 pocket of the active site. Further structure based elaboration of this residue resulted in a novel class of potent and selective inhibitors of uPA. (C) 2001 Elsevier Science Ltd. All rights reserved.
• HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS
  申请人：ZENECA LIMITED

  公开号：EP0690847A1

  公开（公告）日：1996-01-10
• US4105790A
  申请人：——

  公开号：US4105790A

  公开（公告）日：1978-08-08